XML 26 R15.htm IDEA: XBRL DOCUMENT v3.8.0.1
Fair Value Measurements
3 Months Ended
Mar. 31, 2018
Fair Value Disclosures [Abstract]  
Fair Value Measurements

8.  FAIR VALUE MEASUREMENTS:

As required by FASB ASC 820, the Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date and establishes a three-level hierarchy for measuring fair value. Fair value measurements are classified and disclosed in one of the following categories:

 

Level 1:

Quoted prices (unadjusted) in active markets for identical assets and liabilities that the Company has the ability to access at the measurement date.

 

Level 2:

Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable for the asset or liability, including quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in inactive markets, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived from observable market data by correlation or other means. Instruments categorized in Level 2 include non-exchange traded derivatives such as over-the-counter forwards and swaps.

 

Level 3:

Unobservable inputs for the asset or liability, including situations where there is little, if any, market activity for the asset or liability.

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current derivative asset

 

$

 

 

$

25,118

 

 

$

 

 

$

25,118

 

Long-term derivative asset (1)

 

 

 

 

 

7,697

 

 

 

 

 

 

7,697

 

Total derivative instruments

 

$

 

 

$

32,815

 

 

$

 

 

$

32,815

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current derivative liability

 

$

 

 

$

21,036

 

 

$

 

 

$

21,036

 

Long-term derivative liability (2)

 

 

 

 

 

2,418

 

 

 

 

 

 

2,418

 

Total derivative instruments

 

$

 

 

$

23,454

 

 

$

 

 

$

23,454

 

 

(1)

Included in other assets in the Consolidated Balance Sheet.

 

(2)

Included in other long-term obligations in the Consolidated Balance Sheet.

 

The Company entered into commodity derivative contracts and as a result, we expose ourselves to counterparty credit risk.  Credit risk is the potential failure of the counterparty to perform under the terms of a derivative contract.  In order to minimize our credit risk in derivative instruments, we (i) enter into derivative contracts with counterparties that our management has deemed credit worthy as competent and competitive market makers and (ii) routinely monitor and review the credit of our counterparties.  In addition, each of our current counterparties are lenders under our Revolving Credit Facility.  We believe that all of our counterparties are of substantial credit quality.  Other than as provided in our Revolving Credit Facility, we are not required to provide credit support or collateral to any of our counterparties under our derivative contracts, nor are they required to provide credit support to us.  As of March 31, 2018, we did not have any past-due receivables from, or payables to, any of the counterparties of our derivative contracts.

Fair Value of Financial Instruments

The estimated fair value of financial instruments is the estimated amount at which the instrument could be exchanged currently between willing parties. The carrying amounts reported in the Consolidated Balance Sheets for cash and cash equivalents, restricted cash, accounts receivable, and accounts payable approximate fair value due to the immediate or short-term maturity of these financial instruments. The Company uses available market data and valuation methodologies to estimate the fair value of its debt. The valuation assumptions utilized to measure the fair value of the Company’s debt are considered Level 2 inputs.  This disclosure is presented in accordance with FASB ASC Topic 825, Financial Instruments, and does not impact the Company’s financial position, results of operations or cash flows.

 

 

 

March 31, 2018

 

 

December 31, 2017

 

 

 

Carrying

 

 

Estimated

 

 

Carrying

 

 

Estimated

 

 

 

Amount

 

 

Fair Value

 

 

Amount

 

 

Fair Value

 

Term loan, secured, due April 2024

 

$

975,000

 

 

$

972,563

 

 

$

975,000

 

 

$

975,000

 

6.875% Notes, unsecured, due April 2022, issued 2017

 

 

700,000

 

 

 

610,316

 

 

 

700,000

 

 

 

701,750

 

7.125% Notes, unsecured, due April 2025, issued 2017

 

 

500,000

 

 

 

410,000

 

 

 

500,000

 

 

 

505,000

 

Credit Facility, secured, due January 2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

2,175,000

 

 

$

1,992,879

 

 

$

2,175,000

 

 

$

2,181,750